|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weigelt B and Reis-Filho JS: Histological
and molecular types of breast cancer: Is there a unifying taxonomy?
Nat Rev Clin Oncol. 6:718–730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Houessinon A, François C, Sauzay C,
Louandre C, Mongelard G, Godin C, Bodeau S, Takahashi S, Saidak Z,
Gutierrez L, et al: Metallothionein-1 as a biomarker of altered
redox metabolism in hepatocellular carcinoma cells exposed to
sorafenib. Mol Cancer. 15:382016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ooko E, Saeed ME, Kadioglu O, Sarvi S,
Colak M, Elmasaoudi K, Janah R, Greten HJ and Efferth T:
Artemisinin derivatives induce iron-dependent cell death
(ferroptosis) in tumor cells. Phytomedicine. 22:1045–1054. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dixon SJ and Stockwell BR: The role of
iron and reactive oxygen species in cell death. Nat Chem Biol.
10:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewerenz J, Hewett SJ, Huang Y, Lambros M,
Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M,
et al: The cystine/glutamate antiporter system x(c)(−) in health
and disease: From molecular mechanisms to novel therapeutic
opportunities. Antioxid Redox Signal. 18:522–555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gout PW, Buckley AR, Simms CR and
Bruchovsky N: Sulfasalazine, a potent suppressor of lymphoma growth
by inhibition of the x(c)-cystine transporter: A new action for an
old drug. Leukemia. 15:1633–1640. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lo M, Ling V, Low C, Wang YZ and Gout PW:
Potential use of the anti-inflammatory drug, sulfasalazine, for
targeted therapy of pancreatic cancer. Curr Oncol. 17:9–16.
2010.PubMed/NCBI
|
|
12
|
Basuli D, Tesfay L, Deng Z, Paul B,
Yamamoto Y, Ning G, Xian W, McKeon F, Lynch M, Crum CP, et al: Iron
addiction: A novel therapeutic target in ovarian cancer. Oncogene.
36:4089–4099. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KL and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sehm T, Fan Z, Ghoochani A, Rauh M,
Engelhorn T, Minakaki G, Dörfler A, Klucken J, Buchfelder M,
Eyüpoglu IY and Savaskan N: Sulfasalazine impacts on ferroptotic
cell death and alleviates the tumor microenvironment and
glioma-induced brain edema. Oncotarget. 7:36021–36033. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
NaveenKumar SK, SharathBabu BN, Hemshekhar
M, Kemparaju K, Girish KS and Mugesh G: The role of reactive oxygen
species and ferroptosis in heme-mediated activation of human
platelets. ACS Chem Biol. 13:1996–2002. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bogacz M and Krauth-Siegel RL:
Tryparedoxin peroxidase-deficiency commits trypanosomes to
ferroptosis-type cell death. ELife. 7(pii): e375032018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei G, Sun J, Hou Z, Luan W, Wang S, Cui
S, Cheng M and Liu Y: Novel antitumor compound optimized from
natural saponin Albiziabioside A induced caspase-dependent
apoptosis and ferroptosis as a p53 activator through the
mitochondrial pathway. Eur J Med Chem. 157:759–772. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang R, Zhu S, Zeh HJ, Klionsky DJ and
Tang D: BECN1 is a new driver of ferroptosis. Autophagy.
14:2173–2175. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Torti SV, Manz DH, Paul BT,
Blanchette-Farra N and Torti FM: Iron and cancer. Annu Rev Nutr.
38:97–125. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yanatori I and Kishi F: DMT1 and iron
transport. Free Radic Biol Med. 133:55–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sato H, Tamba M, Ishii T and Bannai S:
Cloning and expression of a plasma membrane cystine/glutamate
exchange transporter composed of two distinct proteins. J Biol
Chem. 274:11455–11458. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lo M, Wang YZ and Gout PW: The
x(c)-cystine/glutamate antiporter: A potential target for therapy
of cancer and other diseases. J Cell Physiol. 215:593–602. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Timmerman LA, Holton T, Yuneva M, Louie
RJ, Padró M, Daemen A, Hu M, Chan DA, Ethier SP, van t Veer LJ, et
al: Glutamine sensitivity analysis identifies the xCT antiporter as
a common triple-negative breast tumor therapeutic target. Cancer
Cell. 24:450–465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hasegawa M, Takahashi H, Rajabi H, Alam M,
Suzuki Y, Yin L, Tagde A, Maeda T, Hiraki M, Sukhatme VP and Kufe
D: Functional interactions of the cystine/glutamate antiporter,
CD44v and MUC1-C oncoprotein in triple-negative breast cancer
cells. Oncotarget. 7:11756–11769. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gout PW, Buckley AR, Simms CR and
Bruchovsky N: Sulfasalazine, a potent suppressor of lymphoma growth
by inhibition of the x(c)-cystine transporter: A new action for an
old drug. Leukemia. 15:1633–1640. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang X, Ding CK, Wu J, Sjol J, Wardell S,
Spasojevic I, George D, McDonnell DP, Hsu DS, Chang JT and Chi JT:
Cystine addiction of triple-negative breast cancer associated with
EMT augmented death signaling. Oncogene. 36:4235–4242. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang F and Yang Y: Retraction Note to:
Suppression of the xCT-CD44v antiporter system sensitizes
triple-negative breast cancer cells to doxorubicin. Breast Cancer
Res Treat. 151:4792015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang WS and Stockwell BR: Synthetic lethal
screening identifies compounds activating iron-dependent,
nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.
Chem Biol. 15:234–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao M, Monian P, Quadri N, Ramasamy R and
Jiang X: Glutaminolysis and transferrin regulate ferroptosis. Mol
Cell. 59:298–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamaguchi Y, Kasukabe T and Kumakura S:
Piperlongumine rapidly induces the death of human pancreatic cancer
cells mainly through the induction of ferroptosis. Int J Oncol.
52:1011–1022. 2018.PubMed/NCBI
|
|
34
|
Miller LD, Coffman LG, Chou JW, Black MA,
Bergh J, D'Agostino R Jr, Torti SV and Torti FM: An iron regulatory
gene signature predicts outcome in breast cancer. Cancer Res.
71:6728–6737. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qu Y, Han B, Yu Y, Yao W, Bose S, Karlan
BY, Giuliano AE and Cui X: Evaluation of MCF10A as a reliable model
for normal human mammary epithelial cells. PLoS One.
10:e01312852015. View Article : Google Scholar : PubMed/NCBI
|
